Skip to content

Prospective Randomized Comparison between Pulsed Field Ablation Versus Radiofrequency Ablation for Persistent Atria l Fibrillation:PRAISE trial design

Prospective Randomized Comparison between Pulsed Field Ablation Versus Radiofrequency Ablation for Persistent Atria l Fibrillation:PRAISE trial design

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107157
Enrollment
Unknown
Registered
2025-08-05
Start date
2025-08-15
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

persistent atrial fibrillation

Interventions

PFA group:Pulsed field ablation
RFCA group:Radiofrequency ablation

Sponsors

Beijing Anzhen Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age 18 to 80 years (2) Patients undergoing the first-time AF ablation procedure for non-valvular PeAF, with sustained AF episodes for more than 3 months (3) Left atrial diameter on echocardiography <50 mm (4) Willingness, ability and commitment to provide informed, Consent and participate in follow-up evaluations

Exclusion criteria

Exclusion criteria: (1) AF caused by reversible factors; (2) Echocardiography LVEF = 40, severe pulmonary diseases (e.g., pulmonary arterial hypertension, moderate to severe COPD, asthma, etc.); (15) Expected lifespan < 1 year due to cancer, severe organ failure, etc.; (16) Other situations where the investigator determines the subject is unsuitable for participation in this study.

Design outcomes

Secondary

MeasureTime frame
Quality of Life Questionnaire;

Primary

MeasureTime frame
Atrial arrhythmias lasting over 30 seconds, including atrial fibrillation (AF), atrial flutter (AFL), and atrial tachycardia (AT).;

Countries

China

Contacts

Public ContactDeyong Long

Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing, China

dragon2008@vip.sina.com+86 135 2295 8166

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026